Упрощенная HTML-версия
141
rosis. - 1998. - N 136. - 2. - Р. 305-314.
251. Reid, R.L. et al. Oral contraceptives and venous thromboembolism // J. Fam. Re-
prod. Health Care. - 2010. - N 36(3). - P. 117-22.
252. Richard-Davis, G., Montgomery-Rice, V., Mammen, Е.F. е.а. In vitro platelet
function in controlled ovarian hyperstimulation cycles // Fertil Steril. - 1997. - N
67. - Р. 923-927.
253. Sabra, А., Bonnar, J. Hemostatic system changes induced by 50 micrograms and
30 micrograms estrogen/progestogen oral contraceptives Modification of estrogen
affects by levonorgestrel // J.Reprod. Med. - N 28. - 1. - Р. 85-91.
254. Scouby, S.O. Оral contraceptives and venous thrombosis
the end of the dispute?
// The Eur. J. of Contraception and Reproductive Health Care. - 1998. - N 3. - P.
59-64.
255. Schindler, A.E., Campagnoli, C., Druckmann, R. Claasification and farmacology
of progestins. - Maturitas. - 2003. - N 46(S1). - P. 7-16.
256. Schroder, J., Schneider, В., Oette,l М. Are the antioxidative effects of 17-B-
estradiol modified by concomitant administration of а progestin // Maturitas. -
1996. - N 25. - 2. - Р. 133-139.
257. Shanker, G., Sorci-Thomas, М., Adams, М. R. Estrogen modulates the inducible
expression of platelet-derived growth factor mRNA by mono-cytemacrophages //
Life Sci. - 1995. - N 56. - 7. - Р. 499-507.
258. Shmeleva, V.M. Hyperhomocysteinemia and factor V Leiden act synergistically
increasing risk of vein thrombosis in North-Western Russia // Thrombosis & Hae-
mostasis. - 2007. - Vol.5. - 2. - P. 616.
259. Shmeleva, V.M. Thrombophilic risk profile in patients with venous thromboembo-
lism in North- Western Russia // J. of Thrombosis and Haemostasis. - 2009. -
Vol.7. - Supplement 2. - Abstract PP-TH-321.
260. Sissan, М.А., Leelamma, S. Influence of components of oral contraceptive on lipid
metabolism // Indian J. Exp. Biol. - 1996. - N 34. - 2. - Р. 131- 134.
261. Sitruk-Ware, R. Nath, A. The use of never progestins for contraception // Contra-
ception. - 2010. - N 5. - P. 410-417.